Gerresheimer AG (GXI.DE) XETRA

Currency In EUR

AD

Gerresheimer AG

Address

Klaus-Bungert-Strasse 4

Düsseldorf, NW 40468

Germany

Phone

49 211 61 81 00

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Employees

13528

First IPO Date

June 11, 2007

Key Executives

NameTitlePayYear Born
Uwe Ferdinand RöehrhoffChairman of the Management Board & CEO3M1962
Katja SchnitzlerGlobal Senior Vice President of People & Organization and Member of Supervisory Board124,0001981
Achim SchalkMember of the Management Board813,0001972
Wolf Uwe LehmannChief Financial Officer & Member of the Management Board866,0001971
Carolin NadiloCorporate Director of Investor Relations01986
Ueli UtzingerGroup Senior Director Marketing & Communication0N/A
Guido PickertHead of Investor Relations0N/A
Hans-Norbert ToppHead of Moulded Glass Business Unit01961
AD

Description

Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in the production and sale of packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions. Its Plastics & Devices segment provides a variety of drug administration tools, such as inhalers, insulin pen systems, prefillable syringes, and diagnostic systems, for the pharmaceutical, biotech, diagnostics, and medical technology sectors. This division also manufactures plastic containers, closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and related accessories for solid, liquid, and ophthalmic applications, alongside bottles for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging products for the pharmaceutical and cosmetics industries, including infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; and miniature bottles for liquid food, spices, spirits, fragrances, deodorants, skincare, and wellness products. Lastly, the Advanced Technologies division focuses on developing intelligent drug delivery systems, like micro pumps, designed to enable the self-administration of medication for conditions such as Parkinson's disease or heart failure, serving its pharmaceutical and biotech clients.

AD